Literature DB >> 20502460

Guidelines for the welfare and use of animals in cancer research.

P Workman1, E O Aboagye, F Balkwill, A Balmain, G Bruder, D J Chaplin, J A Double, J Everitt, D A H Farningham, M J Glennie, L R Kelland, V Robinson, I J Stratford, G M Tozer, S Watson, S R Wedge, S A Eccles.   

Abstract

Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer. Excellent standards of animal care are fully consistent with the conduct of high quality cancer research. Here we provide updated guidelines on the welfare and use of animals in cancer research. All experiments should incorporate the 3Rs: replacement, reduction and refinement. Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20502460      PMCID: PMC2883160          DOI: 10.1038/sj.bjc.6605642

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  210 in total

1.  Hypercholesterolemia in rats with hepatomas: increased oxysterols accelerate efflux but do not inhibit biosynthesis of cholesterol.

Authors:  Takeshi Hirayama; Akira Honda; Yasushi Matsuzaki; Teruo Miyazaki; Tadashi Ikegami; Mikio Doy; Guorong Xu; Michael Lea; Gerald Salen
Journal:  Hepatology       Date:  2006-09       Impact factor: 17.425

2.  Realistic rodents? Debate grows over new mouse models of cancer.

Authors:  Ken Garber
Journal:  J Natl Cancer Inst       Date:  2006-09-06       Impact factor: 13.506

3.  A system for LogD screening of 96-well plates using a water-plug aspiration/injection method combined with high-performance liquid chromatography-mass spectrometry.

Authors:  Yukifumi Dohta; Taro Yamashita; Satomi Horiike; Tatsuji Nakamura; Takehiro Fukami
Journal:  Anal Chem       Date:  2007-10-02       Impact factor: 6.986

4.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

Review 5.  Modeling therapy resistance in genetically engineered mouse cancer models.

Authors:  Sven Rottenberg; Jos Jonkers
Journal:  Drug Resist Updat       Date:  2007-12-31       Impact factor: 18.500

6.  Development of gastric adenocarcinoma in Mongolian gerbils after long-term infection with Helicobacter pylori.

Authors:  Qing Zheng; Xiao Yu Chen; Yao Shi; Shu Dong Xiao
Journal:  J Gastroenterol Hepatol       Date:  2004-10       Impact factor: 4.029

Review 7.  Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.

Authors:  Sonu Sundd Singh
Journal:  Curr Drug Metab       Date:  2006-02       Impact factor: 3.731

8.  A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation.

Authors:  Brian T Ragel; Isaac L Elam; David L Gillespie; Jeannette R Flynn; David A Kelly; David Mabey; Harvey Feng; William T Couldwell; Randy L Jensen
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

9.  Adaptation to stress induced by restraining rats and mice in nose-only inhalation holders.

Authors:  Sandy P Narciso; Elizabeth Nadziejko; Lung Chi Chen; Terry Gordon; Christine Nadziejko
Journal:  Inhal Toxicol       Date:  2003-09-15       Impact factor: 2.724

10.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.

Authors:  T Lifsted; T Le Voyer; M Williams; W Muller; A Klein-Szanto; K H Buetow; K W Hunter
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

View more
  615 in total

Review 1.  Designing phenotyping studies for genetically engineered mice.

Authors:  C J Zeiss; J M Ward; H G Allore
Journal:  Vet Pathol       Date:  2011-09-19       Impact factor: 2.221

2.  Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance.

Authors:  Shawna Mae Hengel; Euan Murray; Simon Langdon; Larry Hayward; Jean O'Donoghue; Alexandre Panchaud; Ted Hupp; David R Goodlett
Journal:  J Proteome Res       Date:  2011-09-21       Impact factor: 4.466

3.  Administration of substances to laboratory animals: routes of administration and factors to consider.

Authors:  Patricia V Turner; Thea Brabb; Cynthia Pekow; Mary Ann Vasbinder
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

Review 4.  To Treat or Not to Treat: The Effects of Pain on Experimental Parameters.

Authors:  Norman C Peterson; Elizabeth A Nunamaker; Patricia V Turner
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

5.  Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736.

Authors:  Andrew S Moore; Amir Faisal; Grace W Y Mak; Farideh Miraki-Moud; Vassilios Bavetsias; Melanie Valenti; Gary Box; Albert Hallsworth; Alexis de Haven Brandon; Cristina P R Xavier; Randal Stronge; Andrew D J Pearson; Julian Blagg; Florence I Raynaud; Rajesh Chopra; Suzanne A Eccles; David C Taussig; Spiros Linardopoulos
Journal:  Blood Adv       Date:  2020-04-14

6.  Pathology Principles and Practices for Analysis of Animal Models.

Authors:  Sue E Knoblaugh; Tobias M Hohl; Krista M D La Perle
Journal:  ILAR J       Date:  2018-12-01

7.  Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct.

Authors:  Jan Olof G Karlsson; Tino Kurz; Susanne Flechsig; Jacques Näsström; Rolf Gg Andersson
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

8.  Glioma is formed by active Akt1 alone and promoted by active Rac1 in transgenic zebrafish.

Authors:  In Hye Jung; Ga Lam Leem; Dawoon E Jung; Min Hee Kim; Eun Young Kim; Se Hoon Kim; Hae-Chul Park; Seung Woo Park
Journal:  Neuro Oncol       Date:  2013-01-16       Impact factor: 12.300

9.  A Xenograft Model of Vestibular Schwannoma and Hearing Loss.

Authors:  Christine T Dinh; Olena Bracho; Christine Mei; Esperanza Bas; Cristina Fernandez-Valle; Fred Telischi; Xue-Zhong Liu
Journal:  Otol Neurotol       Date:  2018-06       Impact factor: 2.311

10.  Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma In Vivo with Susceptibility Contrast MRI.

Authors:  Simon P Robinson; Jessica K R Boult; Naveen S Vasudev; Andrew R Reynolds
Journal:  Cancer Res       Date:  2017-05-31       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.